Strides Pharma to manufacture generic version of Pfizer’s Covid-19 oral drug

The Bangalore-based pharmaceutical firm, Stride Pharma Science on Monday made an announcement that it has entered into a sub-agreement with Medicines Patent Pool (MPP) to launch a generic version of Pfizer’s Covid-19 oral treatment in low and middle-income markets. This drug has received emergency use authorization for Covid-10 oral antiviral treatment by the US Food and Drug Administration (USFDA).

The generic version of the drug will be branded as Kovidax and scheduled to be launched in the markets as a part of as part of Strides’ sub-licensing agreement with MPP. The drug will be manufactured at the company’s facility in Bengaluru. Strides Pharma has said that it had already secured its active pharmaceutical ingredients supplies through a preferred partnership arrangement.

The oral drug consists of Nirmatrelvir tablets, which are co-administered with Ritonavir tablets. The treatment has been very effective in reducing the risk of hospitalization and also reduces the death chances by 89 percent within three days of symptom onset..

Latest news

IAS Dr Balkar Singh Takes Charge as CEO of Greater Noida Authority

IAS officer Dr Balkar Singh has been appointed Chief Executive Officer (CEO) of the Greater Noida Authority, along with...

Kishore Seshagiri Joins Vanguard India as Chief Technology Officer

Vanguard India has appointed Kishore Seshagiri as its Chief Technology Officer (CTO). In his new role, he will lead...

Arna Softech Names Chaitanya Mishra as Its New Chief Revenue Officer

Arna Softech has appointed Chaitanya Mishra as its Chief Revenue Officer (CRO). In his new role, he will lead...

IPS Officer Mahesh Bhagwat Takes Charge as Hyderabad Police Commissioner

IPS officer Mahesh Bhagwat has been appointed as the new Commissioner of Police, Hyderabad. His appointment marks a key...
spot_img

You might also likeRELATED
Recommended to you

spot_img